Protein Targeting Compounds

CHF 180.75
Auf Lager
SKU
BSNGNG0894J
Stock 1 Verfügbar
Geliefert zwischen Mo., 27.04.2026 und Di., 28.04.2026

Details

This book presents an overview of the most relevant protein knockdown techniques. Readers will find a description of the generation and use of recombinant human antibodies, ER intrabodies and peptides as well as a description of the working mechanism and potential of the inhibitory action of each of these molecules. The book will also describe the selection and activity of a number of phosphatases, aptamers and allosteric modulators, focusing on A G protein coupled receptors. The book starts with a chapter on the in silico prediction of target-inhibitor interactions.

Key aspects of this book are:

  • Selection strategies for monoclonal and recombinant human antibodies

  • Selection strategies for ER intrabodies, peptides and aptamers
  • Examples of the most efficient inhibitors and their applications in protein biochemistry and cell biology

    • Antibodies for cancer therapy and inhibitors of angiogenesis.

    The book will be of great interest to scientists and students working in the life sciences on all areas related to protein biology. The variety of methods to modulate the activities of specific proteins which are introduced here will be of great benefit to the reader who is interested in general protein research or to readers who have very specific protein related questions.

    A comprehensive overview of strategies for the generation of protein inhibitors Covering prediction, selection and the biological application of protein inhibitors Extensive discussion of future approaches and applications of protein inhibitors

    Inhalt
    Introduction.- Part I Methods of Structure Prediction.- Chapter 1 In Silico Prediction of Target-Inhibitor Interactions.- Part II Antibodies.- Chapter 2 Antibodies and Selection of Monoclonal Antibodies.- Chapter 3 Selection of Recombinant Human Antibodies.- Chapter 4 Selection of Recombinant Human Antibodies against Toxins and Viruses.- Chapter 5 Recent Advances with ER Targeted Intrabodies.- Chapter 6 Therapeutic Blocking Antibodies against Oncogenic Receptors and Growth Factors.- Chapter 7 Synthetic Cystine-Knot Miniproteins-Valuable Scaffolds for Polypeptide Engineering.- Part III Peptides, Small Molecules and Aptamers.- Chapter 8 Peptides and Peptide Analogs to Inhibit Protein.- Chapter 9 Allosteric Modulators of the Class A G Protein coupled Receptors.- Chapter 10 Phosphatases: Their Roles in Cancer and their Chemical Modulators.- Chapter 11 Selection and Application of Aptamers and Intramers.- Part IV Angiogenesis Inhibitors.- Chapter 12 Inhibitors of Angiogenesis.

Weitere Informationen

  • Allgemeine Informationen
    • GTIN 09783319328041
    • Editor Thomas Böldicke
    • Sprache Englisch
    • Auflage 1st edition 2016
    • Größe H241mm x B160mm x T21mm
    • Jahr 2016
    • EAN 9783319328041
    • Format Fester Einband
    • ISBN 3319328042
    • Veröffentlichung 06.06.2016
    • Titel Protein Targeting Compounds
    • Untertitel Prediction, Selection and Activity of Specific Inhibitors
    • Gewicht 665g
    • Herausgeber Springer International Publishing
    • Anzahl Seiten 296
    • Lesemotiv Verstehen
    • Genre Medical Books

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470
Kundenservice: customerservice@avento.shop | Tel: +41 44 248 38 38